Literature DB >> 12620294

NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors.

Ana I Benito1, Eileen Bryant, Michael R Loken, George E Sale, Richard A Nash, M John Gass, H Joachim Deeg.   

Abstract

Sublethally irradiated NOD/SCID mice were transplanted with hematopoietic progenitor cells obtained from the marrow of patients with myelodysplastic syndromes (MDS). Engraftment of MDS cells, as determined by flow cytometry, was delayed compared to marrow from normal donors. Human CD38(+)CD34(-) cells were prominent in marrows and spleens of MDS chimeras. CD34(+)CD38(-), CD34(+)CD38(+) and T cells were also easily detected. Human myeloid cells (CD33(+); CD15(+)) were present in low proportions. No clonal precursors were identified by fluorescent in situ hybridization (FISH) or by molecular analysis of polymorphic X-linked markers in mice with documented engraftment of human cells more than 2 months after transplantation. These data indicate that human cells present in murine MDS chimeras, at the levels of sensitivity of our assays, were derived from residual normal cells in human MDS marrow, and suggest that the NOD/SCID environment was not conducive to the expansion of clonal MDS precursors. This model may allow identification of factors relevant for sustaining or expanding clonal precursors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620294     DOI: 10.1016/s0145-2126(02)00221-7

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  22 in total

Review 1.  Murine xenogeneic models of myelodysplastic syndrome: an essential role for stroma cells.

Authors:  Xiang Li; H Joachim Deeg
Journal:  Exp Hematol       Date:  2013-10-11       Impact factor: 3.084

Review 2.  Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis.

Authors:  Marc H G P Raaijmakers
Journal:  Int J Hematol       Date:  2012-01-06       Impact factor: 2.490

Review 3.  Mouse models of myelodysplastic syndromes.

Authors:  Sarah H Beachy; Peter D Aplan
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

Review 4.  The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression.

Authors:  Allison J Li; Laura M Calvi
Journal:  Exp Hematol       Date:  2017-08-18       Impact factor: 3.084

Review 5.  Revisiting the case for genetically engineered mouse models in human myelodysplastic syndrome research.

Authors:  Ting Zhou; Marsha C Kinney; Linda M Scott; Sandra S Zinkel; Vivienne I Rebel
Journal:  Blood       Date:  2015-06-15       Impact factor: 22.113

6.  Limited engraftment of low-risk myelodysplastic syndrome cells in NOD/SCID gamma-C chain knockout mice.

Authors:  M G Martin; J S Welch; G L Uy; T A Fehniger; S Kulkarni; E J Duncavage; M J Walter
Journal:  Leukemia       Date:  2010-07-29       Impact factor: 11.528

7.  An MDS xenograft model utilizing a patient-derived cell line.

Authors:  G W Rhyasen; M Wunderlich; K Tohyama; G Garcia-Manero; J C Mulloy; D T Starczynowski
Journal:  Leukemia       Date:  2013-12-11       Impact factor: 11.528

8.  Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell.

Authors:  Yang Jo Chung; Chul Won Choi; Christopher Slape; Terry Fry; Peter D Aplan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-03       Impact factor: 11.205

9.  Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome.

Authors:  Yang Jo Chung; Ghanwa Khawaja; Karen M Wolcott; Peter D Aplan
Journal:  J Vis Exp       Date:  2018-10-03       Impact factor: 1.355

Review 10.  A novel role for the marrow microenvironment in initiating and sustaining hematopoietic disease.

Authors:  Aravind Ramakrishnan; H Joachim Deeg
Journal:  Expert Opin Biol Ther       Date:  2009-01       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.